Clinical Trials Update: Oct. 23, 2009

• Ragweed Allergy
• Atrial Fibrillation
• Psoriasis

(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:

Ragweed Allergy

This study will evaluate the safety and effectiveness of an investigational drug. You must be 18 to 50 and have a history of ragweed allergy to qualify.

The research site is in Houston, Texas.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/allergies.aspx.

-----

Atrial Fibrillation

This study of atrial fibrillation is recruiting candidates. The research site is in Philadelphia, Penn.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/atrial_fibrillation.aspx.

-----

Psoriasis

This study will evaluate an investigational medication for psoriasis, a disorder that affects the skin and joints.

The research site is in Baltimore, Md.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/psoriasis.aspx.

-----

Copyright 2009 ClinicalConnection.com. All rights reserved.